首页 | 本学科首页   官方微博 | 高级检索  
检索        


Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms
Institution:1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas;4. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;6. Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas;7. Department of Radiation Oncology, Centre Hospitalier de l''Université de Montréal, Montreal, Quebec, Canada;1. Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey;2. Henry Ford Health System, Detroit, Michigan;3. University of California, San Francisco, San Francisco, California;4. Cedar-Sinai Medical Center, Los Angeles, California;6. MD Anderson Cancer Center, Houston, Texas;5. Yale University, New Haven, Connecticut;1. Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California;2. Center for Precision Radiation Medicine, La Jolla, California;3. Department of Medicine, Division of Hematology and Oncology, University of California San Diego, La Jolla, California;1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;2. Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;3. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;1. Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Australia;2. School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdon;3. Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia;4. Health and Biomedical Informatics Centre, The University of Melbourne, Melbourne, Australia;6. Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia;5. Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia;7. Alfred Health Radiation Oncology Services, Prahran, Australia;11. Central Clinical School, Monash University, Melbourne, Australia
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号